Investigation of change in residence-time in repeated radioimmunotherapy using I-131 rituximab for non-hodgkin's lymphoma

被引：0
|
作者：
Lim, S. [1 ]
Park, J. [1 ]
Kim, K. [1 ]
Kang, H. [1 ]
Choi, T. [1 ]
Kim, J. [1 ]
Woo, S. [1 ]
Kim, J. [1 ]
Kim, B. [1 ]
Cheon, G. [1 ]
机构：
[1] Korea Inst Radiol & Med Sci, Dept Med, Lab Nucl Med Res, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S292 / S292
页数：1
相关论文
共 50 条
  • [1] Safety of 131I-Rituximab Outpatient Radioimmunotherapy of Non-Hodgkin Lymphoma
    Calais, P. J.
    Turner, J. H.
    MEDICAL PHYSICS, 2011, 38 (06)
  • [2] REPEATED RADIOIMMUNOTHERAPY (RIT) WITH I-131 RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS
    Kang, H. J.
    Lim, S. M.
    Cheon, G. J.
    Choi, C. W.
    Lee, S. S.
    Na, I. I.
    Ryoo, B. Y.
    Kim, W. S.
    Nam, S. H.
    Park, Y. H.
    Suh, C.
    Eom, H. S.
    Yang, S. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 100 - 100
  • [3] REPEATED RADIOIMMUNOTHERAPY (RIT) WITH I-131 RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS
    Kang, H. J.
    Lim, S. M.
    Cheon, G. J.
    Choi, C. W.
    Lee, S. S.
    Kim, W. S.
    Park, Y. H.
    Ryoo, B.
    Na, I. I.
    Yang, S. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 232 - 232
  • [4] I-131 Tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: Radiation dose to the testes
    Hattori, Naoya
    Gopal, Ajay
    Fisher, Darrell
    Durack, Lawrence
    Shields, Andrew
    Press, Oliver
    Rajendran, Joseph
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [5] Outpatient 131I-Rituximab Radioimmunotherapy for Non-Hodgkin Lymphoma A Study in Safety
    Calais, Phillipe J.
    Turner, John Harvey
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (08) : 732 - 737
  • [6] Assessment of absorbed dose and therapeutic response of tumor in repeated high-dose I-131 antiCD20 monoclonal antibody (rituximab) radioimmunotherapy for non-Hodgkin's lymphoma
    Byun, B.
    Kim, K.
    Suh, S.
    Kang, H.
    Choi, T.
    Lee, J.
    Woo, S.
    Cheon, G.
    Choi, C.
    Lim, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S360 - S360
  • [7] Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye J.
    Lee, Seung S.
    Kim, Kyeong M.
    Choi, Tae H.
    Cheon, Gi J.
    Kim, Won S.
    Suh, Cheolwon
    Yang, Sung H.
    Lim, Sang M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) : 136 - +
  • [8] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
    Kang, Hye Jin
    Lee, Seung-Sook
    Byun, Byung Hyun
    Kim, Kyeong Min
    Lim, Ilhan
    Choi, Chang Woon
    Suh, Cheolwon
    Kim, Won Seog
    Nam, Seung-Hyun
    Lee, Soon Il
    Eom, Hyeon Seok
    Shin, Dong-Yeop
    Lim, Sang Moo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 945 - 953
  • [9] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin’s lymphoma: initial experience
    Maren Bienert
    Ingrid Reisinger
    Stefanie Srock
    Beatrice I Humplik
    Christel Reim
    Thomas Kroessin
    Norbert Avril
    Antonio Pezzutto
    Dieter L Munz
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 1225 - 1233
  • [10] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma:: initial experience
    Bienert, M
    Reisinger, I
    Srock, S
    Humplik, BI
    Reim, C
    Kroessin, T
    Avril, N
    Pezzutto, A
    Munz, DL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (10) : 1225 - 1233
12345